Global Diabetes Monitors Market, Product Type (Self-Glucose Monitoring Devices, Continuous Glucose Monitoring Devices), Indication (Type-I Diabetes, Type-II Diabetes, Gestational Diabetes), Approach (Invasive, Non-invasive), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Centers, Self-Care), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Get Exclusive Sample Copy of this Report Here
Market Analysis and Insights : Global Diabetes Monitors Market
The diabetes monitors market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 18,171.59 million and grow at a CAGR of 6.52% in the above-mentioned forecast period. Rising expansion of the number of diabetic patients all over the globe drives the diabetes monitors market
Diabetes is a type of condition in which the glucose produced in the body cannot be utilized by it. This is one of the most important source of vitality for human cells. Diabetes treatment is an easy to use and essential method that helps in enhancing the procedure of the treatment of blood glucose monitoring system. As obesity is increasing and standards of living are also improving, diabetes treatment has helped in improving people's living habits, disease control effect is becoming more and more important.
Rapidly changing lifestyle and continuous unhealthy lifestyle is the vital factor escalating the market growth, also rising number of programs initiated by various health organizations related to health awareness, increasing healthcare expenditure, easy access for the treatment due to increasing number of hospitals, rising number of diabetic patients due to unhealthy lifestyle of the people, rising cases of diabetes in young generation due to bad genetics and improper diet are the major factors among others driving the diabetes monitors market. Moreover, rising technological advancements and modernization in the healthcare devices, rising research and development activities in the healthcare sector and rising emerging markets with increasing geriatric population base will further create new opportunities for diabetes monitors market in the forecasted period of 2021-2028.
However, rising accessibility of alternative treatment and rising discrepancy in reimbursement are the major factors among others which will obstruct the market growth, and will further challenge the growth of diabetes monitors market in the forecast period mentioned above.
The diabetes monitors market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diabetes monitors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Diabetes Monitors Market Scope and Market Size
The diabetes monitors market is segmented on the basis of product type, indication, approach and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the diabetes monitors market is segmented into self-glucose monitoring devices and continuous glucose monitoring devices.
- Based on indication, the diabetes monitors market is segmented into type-I diabetes, type-II diabetes, and gestational diabetes.
- Based on approach, the diabetes monitors market is segmented into invasive and non-invasive.
- The diabetes monitors market is also segmented on the basis of end-user into hospitals, clinics, ambulatory surgical centers, home care centers and self-care.
Diabetes Monitors Market Country Level Analysis
The diabetes monitors market is analysed and market size insights and trends are provided by country, product type, indication, approach and end-user as referenced above.
The countries covered in the diabetes monitors market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the diabetes monitors market due to rising number of programs initiated by various health organizations related to health awareness, increasing healthcare expenditure and easy access for the treatment due to increasing number of hospitals in this region. Asia-Pacific is the expected region in terms of growth in diabetes monitors market due to rising improvements in healthcare facilities and reimbursement policies and increase in awareness regarding diabetes preventive care in this region.
The country section of the diabetes monitors market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The diabetes monitors market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for diabetes monitors market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the diabetes monitors market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Diabetes Monitors Market Share Analysis
The diabetes monitors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to diabetes monitors market.
The major players covered in the diabetes monitors market report are Roche Products Limited, Johnson & Johnson Services, Inc., Sanofi-Deutschland GmbH, Novo Nordisk A/S, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., ARKRAY USA, Inc., Bayer AG, Amylin Pharmaceuticals Inc., Abbott, Medtronic Inc., Teva Pharmaceuticals Pvt Ltd., Home Diagnostics Inc., Novartis AG, Eli Lilly and Company, Merck & Co., Inc, AstraZeneca, Boehringer Ingelheim International GmbH. and Takeda Pharmaceutical Company Limited among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-